Cheers Madam
Very interesting look at a metric I virtually never look at, but no doubt ought to. Not doubting the negatives of that ratios trajectory, but I wonder if automation is playing a role in those numbers, leading to higher skilled staff running more complex equipment, maybe probably with a lower price per sample.
Well the only division that did OK in H2, using their revenue and EBIT numbers, was Industrial by my numbers. Life Sci had a slightly worse margin than PCP, and growth for h2 was lower than for h1 - not sure why they crowed about that. Their leverage ratio improved slightly on the PF number after the crap raise.
I tried to short the open, fumbled it, and then got a better price than the open - very rare with bad news that I get away with that.
ALQ Price at posting:
$4.01 Sentiment: Sell Disclosure: Held
(20min delay)